Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.

"Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Most children with this condition lose the ability to walk before their teens, however, there is hope for William as he is ...

Duchenne muscular dystrophy, which primarily affects those of male sex, is an inherited genetic condition that causes muscle weakness. Symptoms usually appear between the ages of two and four and ...

INDIANAPOLIS (WISH) — It’s a devastating diagnosis that changes a child’s life forever, Duchenne muscular dystrophy, or DMD, is a rare and fatal genetic disease that primarily affects boys.

LONDON, ON, May 19, 2025 /CNW/ - On May 25, Canadians are walking, running, and rolling in support of the 30th annual Walk to Defeat Duchenne, the country's only national event dedicated to ...

The CEO at Nottingham-headquartered Blinds 2go is cycling 300km in 24-hours in a bid to raise an impressive £10,000 for ...